112 related articles for article (PubMed ID: 22920872)
1. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
Asnafi V; Ferrier P
Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
[No Abstract] [Full Text] [Related]
2. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
[TBL] [Abstract][Full Text] [Related]
3. TLX1-induced T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Ferrando AA
Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
[TBL] [Abstract][Full Text] [Related]
4. Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.
Shields BJ; Alserihi R; Nasa C; Bogue C; Alexander WS; McCormack MP
Leukemia; 2015 Apr; 29(4):927-38. PubMed ID: 25283843
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
[TBL] [Abstract][Full Text] [Related]
6. Notch in T-ALL: new players in a complex disease.
Koch U; Radtke F
Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206
[TBL] [Abstract][Full Text] [Related]
7. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
McCormack MP; Young LF; Vasudevan S; de Graaf CA; Codrington R; Rabbitts TH; Jane SM; Curtis DJ
Science; 2010 Feb; 327(5967):879-83. PubMed ID: 20093438
[TBL] [Abstract][Full Text] [Related]
8. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
[No Abstract] [Full Text] [Related]
9. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
Van Vlierberghe P; Pieters R; Beverloo HB; Meijerink JP
Br J Haematol; 2008 Oct; 143(2):153-68. PubMed ID: 18691165
[TBL] [Abstract][Full Text] [Related]
10. The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus.
Eyquem S; Chemin K; Fasseu M; Bories JC
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15712-7. PubMed ID: 15496469
[TBL] [Abstract][Full Text] [Related]
11. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
[TBL] [Abstract][Full Text] [Related]
12. T lymphocyte development in p56lck deficient mice: allelic exclusion of the TcR beta locus is incomplete but thymocyte development is not restored by TcR beta or TcR alpha beta transgenes.
Wallace VA; Kawai K; Levelt CN; Kishihara K; Molina T; Timms E; Pircher H; Penninger J; Ohashi PS; Eichmann K
Eur J Immunol; 1995 May; 25(5):1312-8. PubMed ID: 7774634
[TBL] [Abstract][Full Text] [Related]
13. Expression of ets genes in mouse thymocyte subsets and T cells.
Bhat NK; Komschlies KL; Fujiwara S; Fisher RJ; Mathieson BJ; Gregorio TA; Young HA; Kasik JW; Ozato K; Papas TS
J Immunol; 1989 Jan; 142(2):672-8. PubMed ID: 2536061
[TBL] [Abstract][Full Text] [Related]
14. At the crossroads: diverse roles of early thymocyte transcriptional regulators.
Anderson MK
Immunol Rev; 2006 Feb; 209():191-211. PubMed ID: 16448544
[TBL] [Abstract][Full Text] [Related]
15. Defective activation and survival of T cells lacking the Ets-1 transcription factor.
Muthusamy N; Barton K; Leiden JM
Nature; 1995 Oct; 377(6550):639-42. PubMed ID: 7566177
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into the development of T-cell acute lymphoblastic leukemia.
Staal FJ; van Dongen JJ; Langerak AW
Curr Hematol Malig Rep; 2007 Jul; 2(3):176-82. PubMed ID: 20425367
[TBL] [Abstract][Full Text] [Related]
17. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
18. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
[TBL] [Abstract][Full Text] [Related]
19. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
[No Abstract] [Full Text] [Related]
20. The TLX1 oncogene drives aneuploidy in T cell transformation.
De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
